logo
Drinkable sunscreen is the new rage; here's all you need to know about this ‘liquid supplement'

Drinkable sunscreen is the new rage; here's all you need to know about this ‘liquid supplement'

Indian Express07-05-2025

With an increased awareness of skin health and the need to protect it from harmful UV rays, drinkable sunscreen has become a new trend in the wellness industry. But what exactly is it, and can this liquid supplement provide internal defense against damaging UV rays, potentially replacing conventional topical sunscreens? We asked experts.
What is drinkable sunscreen?
The most common type of drinkable sunscreen is a liquid supplement that includes antioxidants, plant extracts such as Polypodium leucotomos, and occasionally vitamins like astaxanthin or beta-carotene, said Dr Karuna Malhotra, an aesthetic physician and cosmetologist from Cosmetic Skin and Homeo Clinic in Rajouri Garden, New Delhi. 'These ingredients are believed to support the skin's ability to fight UV-induced oxidative stress from the inside out,' added Dr Malhotra.
How are they different from regular sunscreens?
Unlike topical sunscreens, which physically block or absorb UV rays, drinkable sunscreens work on a systemic level. 'They don't create a physical barrier on the skin. Instead, they aim to enhance your skin's resilience by reducing the cellular damage caused by sun exposure, albeit from the inside,' said Dr Malhotra.
Are they effective?
These supplements are typically taken orally once daily, ideally before exposure to the sun. However, Dr Malhotra said that the absorption and effectiveness can vary from person to person. 'And it won't work instantly,' said Dr Malhotra.
Concurred Dr Shareefa Chause, dermatologist, Dr Shareefa Skin Care Clinic, Mumbai, and said that drinkable sunscreens work from within and take time to build protection. 'They are not a substitute for topical sunscreen,' she emphasised.
Dr Malhotra noted that while there is some scientific backing for ingredients like Polypodium leucotomos in reducing sunburn risk, she cautioned against seeing drinkable sunscreen as a standalone solution. 'Since the research is limited, the evidence is still evolving, and it should never replace your SPF lotion or sunblock. It can supplement your skincare routine, but relying solely on it could leave your skin unprotected,' said Dr Malhotra.
Topical application is necessary (Photo: Pixabay)
Who is it for?
Dr Malhotra said not everyone is a good fit for drinkable sunscreen. 'It is typically safe for adults, but without a doctor's approval, it might not be appropriate for children, expectant mothers, or those with specific medical concerns, she advised.
What to note before trying it out?
*It is not FDA-approved as a sunscreen.
*No drinkable product can replace broad-spectrum SPF 30+ sunscreen.
*Photosensitive individuals or those with skin disorders should consult a doctor first.
Sun protection is multifaceted: wear sunscreen, seek shade, wear protective clothing, and consider adding antioxidants.
'Drinkable sunscreen might support skin health, but it's not a shortcut. Think of it as an internal antioxidant boost, not a shield. Traditional sunscreen is still your first line of defense. Relying solely on these supplements can give a false sense of security, especially during peak UV hours. For optimal protection, always combine internal care with external sun safety practices,' said Dr Malhotra.
Dr. Chause mentioned that it's safer to continue using proven methods, such as broad-spectrum SPF creams, hats, and shade, while treating drinkable sunscreens only as a possible supplement, not a replacement. 'Don't just blindly use a sunscreen because it has been promoted on social media. Speak to the expert before trying out any product,' said Dr Chause.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

After Zepto in Mumbai, Blinkit in Pune faces action; FDA orders closure of dark store at Baner-Balewadi
After Zepto in Mumbai, Blinkit in Pune faces action; FDA orders closure of dark store at Baner-Balewadi

Indian Express

time3 hours ago

  • Indian Express

After Zepto in Mumbai, Blinkit in Pune faces action; FDA orders closure of dark store at Baner-Balewadi

The Maharashtra Food and Drug Administration (FDA) last week ordered the closure of a dark store associated with quick grocery delivery service Blinkit in Pune's Baner-Balewadi area for allegedly operating without a licence. Suresh Annapure, Joint Commissioner, FDA, Pune, told The Indian Express that the action was taken on June 5 when an inspection team found improper storage conditions at the facility run by Energy Darkstore Services, one of Blinkit's last-mile warehousing and partners. 'We have asked for proper documents to be submitted to issue a license. There are non-compliance issues, and without permission, they have been operating the store in the Baner-Balewadi area,' Annapure said. Sources said several issues were identified, including poor cleanliness and improper cold storage. Food Safety Officer Laxmikant Sawale said the action was taken after the raid revealed a lack of compliance with Schedule 4 of the Food Safety and Standards Act, 2006, which details the general hygienic and sanitary practices that food business operators must adhere to. 'We have directed them to submit a compliance report and then there will be a re-inspection,' Annapure said. The FDA's action is part of its ongoing crackdown on unsafe food storage practices across the state. Earlier this month, it suspended the food business licence of quick-commerce firm Zepto's parent company Kiranakart Technologies due to lapses found at at its dark store in Mumbai's Dharavi. The inspection was conducted by Food Safety Officer Ram Bodke, following instructions from Minister of State for FDA Yogesh Kadam and under the supervision of Mangesh Mane, Joint Commissioner of Food. The investigation revealed numerous violations of the Food Safety and Standards Act, 2006, as well as the related licensing regulations, according to the FDA. Visible fungal growth on food items, stagnant and clogged water near storage areas, which indicated poor sanitation, improper cold storage with temperatures not maintained as per norms, and wet, unclean floors and food products stored haphazardly, including directly on the ground, were some of the findings of the regulator.

Maharashtra FDA suspends food licence of Blinkit dark store in Pune
Maharashtra FDA suspends food licence of Blinkit dark store in Pune

Time of India

time4 hours ago

  • Time of India

Maharashtra FDA suspends food licence of Blinkit dark store in Pune

Maharashtra's Food and Drug Administration (FDA) has suspended the food licence of quick commerce platform Blinkit in Pune 's Balewadi area for not complying with regulations. This comes after the authorities stepped up surveillance of dark stores amid concerns around food safety and hygiene in these facilities. The Maharashtra FDA conducted an investigation on June 5 and found that the facility did not have a licence from the Food Safety and Standards Authority of India for production, distribution or sale of food items. Following this, the facility's food business licence was suspended until the required licence under Section 31 (1) of the Food Safety and Standards Act, 2006, is obtained. Despite the lack of a licence, the Blinkit facility, operated by M/s Energy Darkstore Services near Mitcon College in Balewadi, was storing and selling food items. Blinkit did not respond to detailed queries on the matter. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories In the same order, the authorities noted that the facility had also violated food safety measures. They found food items on the floor, the pest control audit certificate missing, workers in the food area not wearing protective caps, food items stored on dusty racks and a cold storage without a calibration certificate. Last week, a similar probe was conducted at quick commerce platform Zepto's Dharavi facility and its food business licence was suspended after it was found to be in violation of food safety guidelines. The violations included fungal growth on food articles, food storage near stagnant water, the cold storage temperature not being maintained and expired food items unsegregated from the main stock, as per a press note by the FDA. Also Read: Concerns rise over hygiene standards in dark stores amid quick commerce boom

Advent to acquire significant minority stake in animal drug maker Felix Pharmaceuticals for $175 million
Advent to acquire significant minority stake in animal drug maker Felix Pharmaceuticals for $175 million

Mint

time5 hours ago

  • Mint

Advent to acquire significant minority stake in animal drug maker Felix Pharmaceuticals for $175 million

Private equity firm Advent International has signed a definitive agreement to invest $175 million (about ₹ 1,500 crore) for a significant minority stake in Felix Pharmaceuticals Pvt. Ltd, an Ireland-headquartered company focused on developing and manufacturing generic medicines for companion animals such as dogs, cats, and horses. This marks another bet by Advent in the growing healthcare space, this time tapping into the under-penetrated animal health generics segment, where branded drugs continue to dominate. Founded in 2015, Felix Pharma is among the fastest-growing companies in the animal health space, with 14 USFDA-approved products and several more in the pipeline. The company primarily supplies to distributors and other branded generics players, especially in the US, through private labelling. 'Felix has an opportunity to shape the companion animal health generics market. The industry is nascent, with less than 10% share held by generic players, providing a long-term growth opportunity,' said Pankaj Patwari, managing director at Advent, in a statement. 'As we scale in a fast-evolving market, we were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger,' said Neeraj Agrawal, co-founder of Felix. 'Advent's strong track record in healthcare and pharma, and their close involvement in building strong businesses, gives us great confidence,' he added. Felix was co-founded by Neeraj Agrawal, a McKinsey alum, Sir Jonathan Symonds, chair of GSK, and Dr. Shumeet Banerji, former CEO of Booz Allen Hamilton. The company received its first USFDA approval in 2020, and now operates a dedicated R&D centre and a USFDA-approved manufacturing plant for animal health products. The facility includes dedicated oral solids and liquids capabilities tailored specifically for the veterinary generics market. 'Healthcare has been a long-standing focus for us, and strong parallels we see between success in human Gx [generics] globally and emerging opportunity in animal health Gx,' said Shweta Jalan, managing partner at Advent. 'Felix is well positioned to lead this space with its strong leadership, broad portfolio, and robust R&D and commercial capabilities,' she said. The deal comes amid a sharp rise in global demand for animal drugs, as pet ownership and spending on pet healthcare rise across geographies. Advent has been actively investing in Indian healthcare and financial services. In April 2024, it acquired a 12.1% stake in Apollo Healthco, a unit of Apollo Hospitals, for ₹ 2,475 crore. Last year, it invested $230 million in Svatantra Microfin along with Multiples PE, and exited Bharat Serums and Vaccines, selling it to Mankind Pharma for ₹ 13,630 crore.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store